We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current MGRX market cap is 21.41M. The company's latest EPS is USD -0.7890 and P/E is -2.51.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 214k | 163k | 134k | 105k | 109k |
| Operating Income | -2.37M | -2.17M | -1.76M | -2.4M | -4.85M |
| Net Income | -2.37M | -2.39M | -2M | -1.95M | -4.84M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 9k | 731k | 616k |
| Operating Income | -18k | -1.99M | -9.22M | -8.69M |
| Net Income | -18k | -2M | -9.21M | -8.71M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 301k | 15.24M | 14.79M | 15.37M | 21.75M |
| Total Liabilities | 1.26M | 1.41M | 1.4M | 1.43M | 1.5M |
| Total Equity | -958k | 13.83M | 13.39M | 13.95M | 20.25M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 23k | 1M | 1.05M | 15.37M |
| Total Liabilities | 40k | 389k | 276k | 1.43M |
| Total Equity | -17k | 614k | 775k | 13.95M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -991k | -2.57M | -3.73M | -4.86M | -2.28M |
| Investing | N/A | 65k | 65k | 65k | N/A |
| Financing | 267k | 2.26M | 3.01M | 4.13M | 2.29M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -18k | -1.35M | -7M | -4.86M |
| Investing | N/A | -43k | -4k | 65k |
| Financing | 41k | 2.05M | 7.06M | 4.13M |
| Market Cap | 21.41M |
| Price to Earnings Ratio | -2.51 |
| Price to Sales Ratio | 35.48 |
| Price to Cash Ratio | 373.58 |
| Price to Book Ratio | 1.57 |
| Dividend Yield | - |
| Shares Outstanding | 11.03M |
| Average Volume (1 week) | 147.74k |
| Average Volume (1 Month) | 220.89k |
| 52 Week Change | -61.75% |
| 52 Week High | 7.659 |
| 52 Week Low | 1.32 |
| Spread (Intraday) | 0.23 (11.27%) |
| Company Name | Mangoceuticals Inc |
| Address |
15110 n. dallas parkway, suite 600 dallas, texas 75248 |
| Website | https://www.mangorx.com |
| Industry | health & allied services,nec (8099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
